Rituximab for the treatment of type II mixedcryoglobulinemia

被引：47

作者：

Zaja, F ^{[1
]}

De Vita, S

Russo, D

Michelutti, A

Fanin, R

Ferraccioli, G

Baccarani, M

机构：

[1] Policlin Univ, Udine, Italy

[2] Polilin S Orsola, Bologna, Italy

来源：

ARTHRITIS AND RHEUMATISM | 2002年 / 46卷 / 08期

关键词：

D O I：

10.1002/art.10345

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2252 / 2254

页数：3

共 14 条

[1]

Berentsen S, 2000, BLOOD, V96, p730A

[2]

De Vita S, 2000, ARTHRITIS RHEUM, V43, P94, DOI 10.1002/1529-0131(200001)43:1<94::AID-ANR12>3.0.CO

[3]

2-8

[4]

Langford CA, 2001, ARTHRITIS RHEUM-US, V44, P508, DOI 10.1002/1529-0131(200103)44:3<508::AID-ANR96>3.0.CO

[5]

2-B

[6]

Lee E, 2000, BLOOD, V96, p596A

[7] IgM antibody-related polyneuropathies: B-cell depletion chemotherapy using Rituximab [J].

Levine, TD ;

Pestronk, A .

NEUROLOGY, 1999, 52 (08) :1701-1704

[8] Rituximab chimeric Anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma:: Half of patients respond to a four-dose treatment program [J].

McLaughlin, P ;

Grillo-López, AJ ;

Link, BK ;

Levy, R ;

Czuczman, MS ;

Williams, ME ;

Heyman, MR ;

Bence-Bruckler, I ;

White, CA ;

Cabanillas, F ;

Jain, V ;

Ho, AD ;

Lister, J ;

Wey, K ;

Shen, D ;

Dallaire, BK .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) :2825-2833

[9]

Perotta A, 1999, BLOOD, V94, p14A

[10] Anti-CD20 chimeric monoclonal antibody treatment of refractory immune-mediated thrombocytopenia in a patient with chronic graft-versus-host disease [J].

Ratanatharathorn, V ;

Carson, E ;

Reynolds, C ;

Ayash, LJ ;

Levine, J ;

Yanik, G ;

Silver, SM ;

Ferrara, JLM ;

Uberti, JP .

ANNALS OF INTERNAL MEDICINE, 2000, 133 (04) :275-279

← 1 2 →